Lantheus Holdings, Inc. to Present at Upcoming Investor Conferences

NORTH BILLERICA, Mass.–(BUSINESS WIRE)– Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent
company of Lantheus Medical Imaging, Inc. (“LMI”), today announced that
Mary Anne Heino, President and Chief Executive Officer, and Jack
Crowley, Chief Financial Officer, will participate in analyst-led
fireside chat discussions at the following investor conferences taking
place in September 2016.

• Wells Fargo Securities Healthcare Conference
  September 7,
  2016 at 11:05 a.m. ET
  Westin Waterfront Hotel in Boston

• Baird 2016 Global Healthcare Conference
  September 8, 2016
  at 10:15 a.m. ET
  New York Palace Hotel in New York

To access a live webcast of the discussions, please visit the Investors
section of the Company’s website at www.lantheus.com.
A replay of the webcasts will be available on the Company’s website for
30 days following the live discussions.

About Lantheus Holdings, Inc. and Lantheus Medical Imaging, Inc.
Lantheus
Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc.,
a global leader in the development, manufacture and commercialization of
innovative diagnostic imaging agents and products. LMI provides a broad
portfolio of products, which are primarily used for the diagnosis of
cardiovascular diseases. LMI’s key products include the echocardiography
contrast agent DEFINITY^® Vial for (Perflutren Lipid
Microsphere) Injectable Suspension; TechneLite^® (Technetium
Tc99m Generator), a technetium-based generator that provides the
essential medical isotope used in nuclear medicine procedures; and Xenon
(Xenon Xe 133 Gas), an inhaled radiopharmaceutical imaging agent used to
evaluate pulmonary function and for imaging the lungs. LMI is
headquartered in North Billerica, Massachusetts with offices in Puerto
Rico and Canada. For more information, visit www.lantheus.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160824006061/en/